About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Technicals
+12 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Profit & Loss
Novartis India Ltd
Pharmaceuticals - Multinational
BSE Code:
500672
NSE Symbol:
NOVARTIND
P/E :
42.59
ISIN Demat:
INE234A01025
Div & Yield %:
1.48
EPS :
39.6
Book Value:
331.23
Market Cap (Rs. Cr.):
4,164.60
Face Value :
5
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
INCOME :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Sales Turnover
376.96
390.09
366.84
413.52
486.66
453.73
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
376.96
390.09
366.84
413.52
486.66
453.73
Other Income
38.77
41.96
61.68
58.11
33.19
33.09
Stock Adjustments
12.21
-3.75
-9.86
-2.35
9.12
-10.74
Total Income
427.94
428.30
418.66
469.28
528.97
476.08
EXPENDITURE :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Raw Materials
210.58
199.07
189.98
199.34
187.26
135.88
Power & Fuel Cost
0.11
0.14
0.18
0.35
0.53
0.53
Employee Cost
21.08
18.72
22.96
35.64
101.89
108.51
Other Manufacturing Expenses
9.59
8.18
5.00
12.58
31.15
33.51
Selling & Administrative Expenses
47.39
59.74
65.55
82.78
144.40
128.11
Miscellaneous Expenses
6.32
9.07
8.05
15.40
53.08
9.66
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
295.07
294.92
291.72
346.09
518.31
416.20
Operating Profit
132.87
133.38
126.94
123.19
10.66
59.88
Interest
1.26
0.77
1.49
1.75
4.83
7.68
Gross Profit
131.61
132.61
125.45
121.44
5.83
52.20
Depreciation
1.95
2.19
2.61
6.06
9.65
12.16
Profit Before Tax
129.66
130.42
122.84
115.38
-3.82
40.04
Tax
34.95
29.96
37.63
1.68
-0.44
22.62
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
1.53
-0.44
0.02
10.34
0.34
-3.48
Reported Net Profit
93.18
100.90
85.19
103.36
-3.72
20.90
Extraordinary Items
-0.02
0.14
1.99
0.17
-44.68
0.03
Adjusted Net Profit
93.20
100.76
83.20
103.19
40.96
20.87
Adjustment below Net Profit
1.42
0.97
1.21
3.11
8.19
-6.09
P & L Balance brought forward
768.98
728.84
759.72
677.94
698.16
708.04
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
61.73
61.73
117.28
24.69
24.69
24.69
P & L Balance carried down
801.85
768.98
728.84
759.72
677.94
698.16
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
500.00
500.00
500.00
950.00
200.00
200.00
Dividend Per Share(Rs)
25.00
25.00
25.00
47.50
10.00
10.00
Earnings Per Share-Unit Curr
37.76
40.88
34.52
41.88
-1.51
8.47
Earnings Per Share(Adj)-Unit Curr
37.76
40.88
34.52
41.88
-1.51
8.47
Book Value-Unit Curr
331.37
318.06
301.79
314.29
280.27
288.16
Book Value(Adj)-Unit Curr
331.37
318.06
301.79
314.29
280.27
288.16